Skip to main content
. 2020 Oct 29;12:10861–10874. doi: 10.2147/CMAR.S266069

Table 1.

Characteristics of 579 Patients with NSCLC

Characteristic No. of Patients (%)
Total Aged ≤40 Years Aged >40 Years P Smoking Nonsmoking P
No. of patients 579 36 543 225 354
Age: Median (range), y 58 (23–89) 38 (23–40) 59 (40–89) 58 (23–89) 58 (25–84)
Sex
 Male 333 (57.5) 18 (50.0) 315 (58.0) 0.34 223 (99.1) 110 (31.0) <0.001a
 Female 246 (42.5) 18 (50.0) 228 (42.0) 2 (0.9) 244 (69.0)
Histology
 Adenocarcinoma 524 (90.5) 36 (100.0) 488 (90.0) 0.08 193 (85.7) 331 (93.5)
 Squamous cell carcinoma 46 (8.0) 0 (0) 46 (8.4) 26 (11.5) 20 (5.6) <0.05a
 Large cell lung carcinoma 1 (0.2) 0 (0) 1 (0.2) 1 (0.5) 0 (0.0)
 NSCLC 8 (1.3) 0 (0) 8 (1.4) 5 (2.3) 3
Stage
 I 84 (14.5) 3 (8.3) 79 (14.5) 0.02a 19 (8.4) 58 (16.3) 0.58
 II 19 (3.3) 0 (0) 19 (3.5) 6 (2.6) 13 (3.8)
 III 115 (19.9) 4 (11.2) 106 (19.5) 52 (23.2) 58 (16.3)
 IV 361 (62.3) 29 (80.5) 339 (62.5) 148 (65.8) 225 (63.6)
Family history of malignancy
 Yes 28 (4.8) 2 (5.5) 26 (4.8) 0.84 6 (2.6) 22 (6.2) 0.05
 No 551 (95.2) 34 (94.5) 517 (95.2) 219 (97.4) 332 (93.8)
Xuanwei origin
 Yes 119 (20.6) 3 (8.3) 116 (21.4) 0.06 53 (23.5) 66 (18.6) 0.15
 No 460 (79.4) 33 (91.7) 427 (78.6) 172 (76.5) 288 (81.4)

Note: aThis p value indicates a statistically significant difference.